Skip to main navigation Skip to search Skip to main content

A phase III open-label safety and efficacy study of tomoxetine hydrochloride in outpatients with ADHD, Ages 6 to 18 years

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalProtocol * B4Z-MC-LYAB(a),
StatePublished - Oct 1 2000

Disciplines

  • Psychiatry

Cite this